Molecular epidemiology of human papillomavirus genotype in women with high-grade squamous intraepithelial lesion and cervical cancer: Will a quadrivalent vaccine be necessary in Thailand?

Journal of Medical Virology

Volumn 83, Issue 1, 2011, Pages 119-126

  Sukasem, Chonlaphat ^a   Pairoj, Wantanich ^a   Saekang, Nipa ^a   Pombubpha, Hiranyaratsami ^b   Srichunrasami, Chutatip ^a   Pongtippan, Atcharaporn ^a   Junyangdikul, Pairoj ^b   Chantratita, Wasun ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b Samitivej Srinakarin Hospital   (Thailand)

Author keywords

High grade squamous intraepithelial lesion; HPV genotype; Invasive cervical cancer; Thailand

Indexed keywords

WART VIRUS VACCINE;

ADULT; ARTICLE; CANCER INVASION; CLINICAL ASSESSMENT; COLPOSCOPY; CORRELATION ANALYSIS; FEMALE; GENOTYPE; HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 6; HUMAN PAPILLOMAVIRUS TYPE 68; MAJOR CLINICAL STUDY; MOLECULAR EPIDEMIOLOGY; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTION; THAILAND; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; VACCINE PRODUCTION; VIRAL GENETICS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CERVICAL INTRAEPITHELIAL NEOPLASIA; COLPOSCOPY; DNA, VIRAL; FEMALE; GENOTYPE; HUMANS; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; MOLECULAR EPIDEMIOLOGY; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; PROSPECTIVE STUDIES; THAILAND; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; VIROLOGY; YOUNG ADULT;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 78649567059     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21948     Document Type: Article

References (35)

1. Bao YP, Li N, Smith JS, Qiao YL. 2008. Human papillomavirus type-distribution in the cervix of Chinese women: A meta-analysis. Int J STD AIDS 19: 106-111.
2. Bayas JM, Costas L, Muñoz A. 2008. Cervical cancer vaccination indications, efficacy, and side effects. Gynecol Oncol 110: S11-S14.
3. Beerens E, van Renterghem L, Praet M, Sturtewagen Y, Weyers S, Temmerman M, Depypere H, Claeys P, Cuvelier CA. 2005. Human papillomavirus DNA detection in women with primary abnormal cytology of the cervix: Prevalence and distribution of HPV genotypes. Cytopathology 16: 199-205.
4. Bhatla N, Lal N, Bao YP, Ng T, Qiao YL. 2008. A meta-analysis of human papillomavirus type-distribution in women from South Asia: Implications for vaccination. Vaccine 26: 2811-2817.
5. Bhattarakosol P, Lertworapreecha M, Kitkumthorn N, Triratanachai S, Niruthisard S. 2002. Survey of human papillomavirus infection in cervical intraepithelial neoplasia in Thai women. J Med Assoc Thai 85: S360-S365.
6. Bollen LJ, Chuachoowong R, Kilmarx PH, Mock PA, Culnane M, Skunodom N, Chaowanachan T, Jetswang B, Neeyapun K, Asavapiriyanont S, Roongpisuthipong A, Wright TC, Tappero JW. 2006. Human papillomavirus (HPV) detection among human immunodeficiency virus-infected pregnant Thai women: Implications for future HPV immunization. Sex Transm Dis 33: 259-264.
7. Castellsagué X, Díaz M, de Sanjosé S, Muñoz N, Herrero R, Franceschi S, Peeling RW, Ashley R, Smith JS, Snijders PJ, Meijer CJ, Bosch FX, International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. 2006. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: Implications for screening and prevention. J Natl Cancer Inst 98: 303-315.
8. Chandeying V, Garland SM, Tabrizi SN. 2006. Prevalence and typing of human papilloma virus (HPV) among female sex workers and outpatient women in southern Thailand. Sex Health 3: 11-14.
9. Chopjitt P, Ekalaksananan T, Pientong C, Kongyingyoes B, Kleebkaow P, Charoensri N. 2009. Prevalence of human papillomavirus type 16 and its variants in abnormal squamous cervical cells in Northeast Thailand. Int J Infect Dis 13: 212-219.
10. Clifford GM, Smith JS, Aguado T, Franceschi S. 2003a. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: A meta-analysis. Br J Cancer 89: 101-105.
11. Clifford GM, Smith JS, Plummer M, Muñoz N, Franceschi S. 2003b. Human papillomavirus types in invasive cervical cancer worldwide: A meta-analysis. Br J Cancer 88: 63-73.
12. Clifford GM, Gallus S, Herrero R, Muñoz N, Snijders PJ, Vaccarella S, Anh PT, Ferreccio C, Hieu NT, Matos E, Molano M, Rajkumar R, Ronco G, de Sanjosé S, Shin HR, Sukvirach S, Thomas JO, Tunsakul S, Meijer CJ, Franceschi S, IARC HPV Prevalence Surveys Study Group. 2005. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: A pooled analysis. Lancet 366: 991-998.
13. de Sanjosé S, Alemany L, Castellsagué X, Bosch FX. 2008. Human papillomavirus vaccines and vaccine implementation. Womens Health (Lond Engl) 4: 595-604.
14. Domingo EJ, Noviani R, Noor MR, Ngelangel CA, Limpaphayom KK, Thuan TV, Louie KS, Quinn MA. 2008. Epidemiology and prevention of cervical cancer in Indonesia, Malaysia, the Philippines, Thailand and Vietnam. Vaccine 12: M71-M79.
15. Fidan I, Bozdayi G, Rota S, Biri A, Gurelik FC, Yuksel S, Imir T. 2008. The relationship between cervical human papillomavirus infection and apoptosis. Clin Invest Med 31: E168-E175.
16. Gargiulo F, De Francesco MA, Schreiber C, Ciravolo G, Salinaro F, Valloncini B, Manca N. 2007. Prevalence and distribution of single and multiple HPV infections in cytologically abnormal cervical samples from Italian women. Virus Res 125: 176-182.
17. Gupta S, Sodhani P, Sharma A, Sharma JK, Halder K, Charchra KL, Sardana S, Singh V, Sehgal A, Das BC. 2008. Prevalence of high-risk human papillomavirus type 16/18 infection among women with normal cytology: Risk factor analysis and implications for screening and prophylaxis. Cytopathology 20: 249-255.
18. Huh WK, Roden RB. 2008. The future of vaccines for cervical cancer. Gynecol Oncol 109: S48-S56.
19. Liak KL, Hsing AW, Schiffman MH, You SL, Zhang T, Burk R, Chen CJ. 1997. Human papillomavirus types 52 and 58 are prevalent in cervical cancer from Chinese women. Int J Cancer 73: 775-776.
20. Lowy DR, Solomon D, Hildesheim A, Schiller JT, Schiffman M. 2008. Human papillomavirus infection and the primary and secondary prevention of cervical cancer. Cancer 113: 1980-1993.
21. Muñoz N. 2000. Human papillomavirus and cancer: The epidemiological evidence. J Clin Virol 19: 1.
22. Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, Snijders PJ, Meijer CJ, International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. 2003. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348: 518-527.
23. Oaknin A, Barretina MP. 2008. Human papillomavirus vaccine and cervical cancer prevention. Clin Transl Oncol 10: 804-811.
24. Prinsen CF, Fles R, Wijnen-Dubbers CW, de Valk HA, Klaassen CH, Mravunac M, Horrevorts AM, Thunnissen FB. 2007. Baseline human papillomavirus status of women with abnormal smears in cervical screening: A 5-year follow-up study in The Netherlands. BJOG 114: 951-957.
25. Rousseau MC, Villa LL, Costa MC, Abrahamowiez M, Rohan TE, Franco E. 2003. Occurrence of vertical infection with multiple human papillomavirus types is associated with age and cytologic abnormalities. Sex Trasm Dis 30: 581-587.
26. Sandri MT, Riggio D, Salvatici M, Passerini R, Zorzino L, Boveri S, Radice D, Spolti N, Sideri M. 2009. Typing of human papillomavirus in women with cervical lesions: Prevalence and distribution of different genotypes. J Med Virol 81: 271-277.
27. Sasagawa T, Basha W, Yamazaki H, Inoue M. 2001. High-risk and multiple human papillomavirus infections associated with cervical abnormalities in japanese women. Cancer Epidemiol Biomark Prev 10: 45-52.
28. Siriaunkgul S, Suwiwat S, Settakorn J, Khunamornpong S, Tungsinmunkong K, Boonthum A, Chaisuksunt V, Lekawanvijit S, Srisomboon J, Thorner PS. 2008. HPV genotyping in cervical cancer in Northern Thailand: Adapting the linear array HPV assay for use on paraffin-embedded tissue. Gynecol Oncol 108: 555-560.
29. Sirivongrangson P, Bollen LJ, Chaovavanich A, Suksripanich O, Virapat P, Tunthanathip P, Ausavapipit J, Lokpichat S, Siangphoe U, Jirarojwat N, Pobkeeree V, Supawitkul S, Tappero JW, Levine WC. 2007. Screening HIV-infected women for cervical cancer in Thailand: Findings from a demonstration project. Sex Transm Dis 34: 104-107.
30. Straif K, Baan R, Grosse Y, Secretan B, El Ghissassi F, Cogliano V, WHO International Agency for Research on Cancer Monograph Working Group. 2005. Carcinogenicity of human papillomaviruses. Lancet Oncol 6: 204.
31. Sukvirach S, Smith JS, Tunsakul S, Muñoz N, Kesararat V, Opasatian O, Chichareon S, Kaenploy V, Ashley R, Meijer CJ, Snijders PJ, Coursaget P, Franceschi S, Herrero R. 2003. Population-based human papillomavirus prevalence in Lampang and Songkla, Thailand. J Infect Dis 187: 1246-1256.
32. Tungsinmunkong K, Suwiwat S, Sriplung H. 2006. Detection of human papillomavirus in intraepithelial lesions and carcinoma of the cervix uteri in southern Thai women. Asian Pac J Cancer Prev 7: 427-430.
33. Wheeler CM, Hunt WC, Joste NE, Key CR, Quint WG, Castle PE. 2009. Human papillomavirus genotype distributions: Implications for vaccination and cancer screening in the United States. J Cancer Inst 101: 475-487.
34. WHO. 2007. WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre). Summaryreport on HPV and cervical cancer statistics in Thailand. available on
35. Zhao Y, Lin H, Shen D, Xuan Y, Lin Z. 2008. Distribution of HPV genotypes in uterine cervical lesions in Yanbian, northern China. Pathol Int 58: 643-647.